Literature DB >> 6153627

Studies on circulating immune complexes of the liver disease. 3. Conditions for Clq binding assay and low molecular weight Clq reactants.

T Arima, J Narumoto, H Shimomura, K Suwaki, K Kunishi, T Yasuhara, H Nagashima.   

Abstract

Assay conditions for Clq binding activity (ClqBA) of aggregated human gamma globulin and pathologic sera were studied. The Clq component of complement was isolated by precipitation method and effectively radioiodinated using lactoperoxidase without loss of binding activity. The assay method was reproducible and the binding activity of normal sera was 5.0 +/- 2.4% (mean +/- S.D.). Amount of 125I-Clq, in the range of 50--1000 ng per assay tube, did not influence the binding activity. Competitive inhibition of intrinsic Clq was very limited. Sample sera for the determination can be stored at --20 degrees C and freezing-throwing of the sera did not increase ClqBA. In normal sera, the existence of solubilizer of Clq-reactant-complex or inhibitor of Clq-reactant binding working at 37 degrees C is suggested. For the low molecular weight reactants in pathologic sera reacting with Clq at 4 degrees C, following substances are proposed: 1. abnormal IgG, 2. hapten-IgG complexes or 3. anionic substances.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6153627     DOI: 10.1007/BF02773700

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  29 in total

1.  Further studies on an eleventh case of heavy (Hgamma1) chain disease--physico-chemical studies.

Authors:  T Arima; C Miyamoto-Sudo; M Hiroata; T Tanigawa; S Tsuboi
Journal:  Acta Med Okayama       Date:  1975-06       Impact factor: 0.892

2.  Further studies on an eleventh case of heavy (Hgamma1) chain disease--clinical studies.

Authors:  T Arima; C Miyamoto-Sudo; M Hiroata; T Tanigawa; S Tsuboi
Journal:  Acta Med Okayama       Date:  1975-06       Impact factor: 0.892

3.  Isolation of a thermolabile serum protein which precipitates gamma-globulin aggregates and participates in immune hemolysis.

Authors:  H J MULLER-EBERHARD; H G KUNKEL
Journal:  Proc Soc Exp Biol Med       Date:  1961-02

4.  A Clq immunosorbent assay compared with thin-layer gel filtration for measuring IgG aggregates.

Authors:  S Ahlstedt; L A Hanson; C Wadsworth
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

5.  Low molecular weight C1q-precipitins in hypocomplementemic vasculitis-urticaria syndrome: partial purification and characterization as immunoglobulin.

Authors:  R J Marder; F X Burch; F R Schmid; C R Zeiss; H Gewurz
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

6.  Use of lactoperoxidase catalyzed iodination in immunochemical studies.

Authors:  M Morrison; G S Bayse; R G Webster
Journal:  Immunochemistry       Date:  1971-03

7.  Evidence for a serum inhibitor of Clq.

Authors:  J D Conradie; J E Volanakis; R M Stroud
Journal:  Immunochemistry       Date:  1975-12

8.  C1g precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: characterization of high and low molecular weight types.

Authors:  V Agnello; D Koffler; J W Eisenberg; R J Winchester; H G Kundel
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

9.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Authors:  R H Zubler; G Lange; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

10.  C1q deviation test for the detection of immune complexes, aggregates of IgG, and bacterial products in human serum.

Authors:  A T Sobel; V A Bokisch; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

View more
  4 in total

1.  Studies on circulating soluble immune complexes of the liver disease. 6. Comparative studies of 125I-pRF inhibition assay, 125I-Clq inhibition assay and 125I-Clq binding assay.

Authors:  J Narumoto
Journal:  Gastroenterol Jpn       Date:  1981

2.  Studies on circulating immune complexes of the liver disease. 4. Clq binding activity.

Authors:  T Arima; J Narumoto; H Shimomura; K Suwaki; K Kunishi; T Yasuhara; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1980

3.  Studies on circulating immune complexes of the liver diseases. 5. Anti-DNA antibodies and C1q binding activity.

Authors:  T Arima; J Narumoto; H Shimomura; T Yasuhara; K Kunishi; K Suwaki; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1980-04

4.  Studies on circulating soluble immune complexes of the liver disease. 7. Immune complexes in the clinical course and their ultracentrifugal analysis.

Authors:  J Narumoto
Journal:  Gastroenterol Jpn       Date:  1981
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.